{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:53:02Z","timestamp":1785498782172,"version":"3.56.0"},"reference-count":17,"publisher":"Bioscientifica","issue":"10","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":140,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The 2022 recommendations of the European Calcified Tissue Society (ECTS) suggest initiating anti-osteoporotic medication (AOM) in case of a T-score \u2264 \u22122 and\/or in case of a fragility fracture within less than 2 years. Therefore, this study aimed to evaluate the eligibility for AOM in a cohort of patients referred for bone health assessment after bariatric surgery. This observational, cross-sectional, and monocentric study conducted at Lille University Hospital evaluated the prevalence of AOM eligibility according to the ECTS criteria in postmenopausal women and men aged \u226550 years referred for bone health assessment after bariatric surgery, either Roux-en-Y gastric bypass or sleeve gastrectomy, at least 2 years after bariatric surgery. Between June 2019 and June 2023, all participants were referred for bone health assessment, including systematic screening using dual-energy X-ray (DXA) and a standardized questionnaire by a radiology technician. Data between June 2023 and May 2024 were retrospectively reviewed. Among 140 patients (120 women, with an average age of 59 (55\u201363) years) seen for bone health assessment between June 2019 and June 2023, 33 met the ECTS guidelines for AOM, indicating a prevalence of 24% (CI 95%: 17\u201331%). Most patients met the BMD T-score \u2264 \u22122 criterion (n = 26\/140, 19% (CI 95%: 12\u201325%)) and\/or had a recent fragility fracture history (n = 14\/140, 10% (CI 95%: 5\u201315%)). In this study, one-fourth of the participants were eligible for AOM according to the ECTS guidelines.<\/jats:p>","DOI":"10.1530\/ec-25-0368","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:22:11Z","timestamp":1759141331000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and risk factors of eligibility for anti-osteoporosis medication in a cohort of men \u226550 years and postmenopausal women who had already experienced bariatric surgery"],"prefix":"10.1530","volume":"14","author":[{"given":"Thomas","family":"Flament","sequence":"first","affiliation":[{"name":"CHU Lille, Rheumatology Department 1 , ,","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Verkindt","sequence":"additional","affiliation":[{"name":"CHU Lille, Endocrine and Metabolic Surgery Department 2 , ,","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Mortain","sequence":"additional","affiliation":[{"name":"CHU Lille, Biostatistics Department 3 , ,","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Pattou","sequence":"additional","affiliation":[{"name":"CHU Lille, Endocrine and Metabolic Surgery Department 2 , ,","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6599-8623","authenticated-orcid":true,"given":"Julien","family":"Paccou","sequence":"additional","affiliation":[{"name":"University Lille, CHU Lille, MABlab ULR 4490, Rheumatology Department 4 , ,","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"2026070711004725800_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jama.2020.12567","article-title":"Benefits and risks of bariatric surgery in adults: a review","volume":"324","author":"Arterburn","year":"2020","journal-title":"JAMA"},{"key":"2026070711004725800_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2024.0318","article-title":"Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes","volume":"331","author":"Courcoulas","year":"2024","journal-title":"JAMA"},{"key":"2026070711004725800_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00223-020-00798-w","article-title":"Bariatric surgery and osteoporosis","volume":"110","author":"Paccou","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"2026070711004725800_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105443","article-title":"French recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery","volume":"89","author":"Paccou","year":"2022","journal-title":"Joint Bone Spine"},{"key":"2026070711004725800_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jbm4.10048","article-title":"Bone health after bariatric surgery","volume":"2","author":"Gagnon","year":"2018","journal-title":"JBMR Plus"},{"key":"2026070711004725800_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116236","article-title":"Bariatric surgery and skeletal health: a narrative review and position statement for management by the European Calcified Tissue Society (ECTS)","volume":"154","author":"Paccou","year":"2022","journal-title":"Bone"},{"key":"2026070711004725800_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3390\/nu15041007","article-title":"An evaluation of the implementation of the European Calcified Tissue Society recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery","volume":"15","author":"Courtalin","year":"2023","journal-title":"Nutrients"},{"key":"2026070711004725800_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101435","article-title":"Executive summary of the 2023 adult position development conference of the international society for clinical densitometry: DXA reporting, follow-up BMD testing and trabecular bone score application and reporting","volume":"27","author":"Shuhart","year":"2024","journal-title":"J Clin Densitom"},{"key":"2026070711004725800_bib9","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/jbmr.2826","article-title":"The effects of age, adiposity, and physical activity on the risk of seven site-specific fractures in postmenopausal women","volume":"31","author":"Lacombe","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2026070711004725800_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2011.06.013","article-title":"Obesity is not protective against fracture in postmenopausal women: glow","volume":"124","author":"Compston","year":"2011","journal-title":"Am J Med"},{"key":"2026070711004725800_bib11","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jbmr.3101","article-title":"Fracture risk after bariatric surgery: roux-en-y gastric bypass versus adjustable gastric banding","volume":"32","author":"Yu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"2026070711004725800_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.soard.2022.04.014","article-title":"Bariatric surgery outcomes in geriatric patients: a contemporary, nationwide analysis","volume":"18","author":"Mabeza","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"2026070711004725800_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"key":"2026070711004725800_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1210\/endrev\/bnaf010","article-title":"Bone in parathyroid diseases revisited: evidence from epidemiological, surgical and new drug outcomes","volume":"46","author":"Roumpou","year":"2025","journal-title":"Endocr Rev"},{"key":"2026070711004725800_bib15","article-title":"Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery","volume":"14","author":"Liu","year":"2021","journal-title":"Bone Rep"},{"key":"2026070711004725800_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/oby.24214","article-title":"Zoledronic acid increases spine bone mass and prevents hip bone loss after bariatric surgery: a randomized placebo-controlled study","volume":"33","author":"Gam","year":"2025","journal-title":"Obesity"},{"key":"2026070711004725800_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057483","article-title":"Protocol for a pilot randomised controlled trial of zoledronic acid to prevent bone loss following sleeve gastrectomy surgery","volume":"11","author":"Flores","year":"2021","journal-title":"BMJ Open"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/10\/EC-25-0368.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/10\/EC-25-0368.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0368\/9789\/ec-25-0368.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0368\/9789\/ec-25-0368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:32:29Z","timestamp":1783438349000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/10\/e250368\/1435\/Prevalence-and-risk-factors-of-eligibility-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0368","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"article-number":"e250368"}}